What is the current Bioporto A/S market capitalization?
The current market capitalization of Bioporto A/S is 580.77 M DKK.
Bioporto A/S Market capitalization 2024
Bioporto A/S Market capitalization
580.77 M DKK
Bioporto A/S Dividend yield
Ticker
BIOPOR.CO
ISIN
DK0011048619
WKN
893191
In 2024, Bioporto A/S's market cap stood at 580.77 M DKK, a 47.49% increase from the 393.77 M DKK market cap in the previous year.
The Bioporto A/S Market capitalization history
| YEAR | REVENUE (undefined DKK) | GROSS MARGIN (%) | NET INCOME (undefined DKK) |
|---|---|---|---|
| 2025e | 23.01 | 87,70 | -87,162.99 |
| 2024e | 40.4 | 49,96 | -38,345.36 |
| 2023 | 30.96 | 65,19 | -56,328 |
| 2022 | 28.97 | 65,73 | -75,923 |
| 2021 | 24.25 | 62,01 | -57,113 |
| 2020 | 23.2 | 57,49 | -61,562 |
| 2019 | 26.62 | 65,09 | -69,642 |
| 2018 | 26.02 | 68,55 | -38,048 |
| 2017 | 25.16 | 72,54 | -32,243 |
| 2016 | 20.72 | 75,74 | -22,800 |
| 2015 | 20.38 | 75,95 | -10,732 |
| 2014 | 18.71 | 70,55 | -12,926 |
| 2013 | 16.63 | 54,36 | -20,620 |
| 2012 | 17.86 | 61,93 | -14,700 |
| 2011 | 18.58 | 9,31 | -14,840 |
| 2010 | 13.8 | 1,45 | -14,210 |
| 2009 | 11.01 | -15,53 | -15,950 |
| 2008 | 9.88 | -27,53 | -14,740 |
| 2007 | 8.34 | -45,08 | -14,260 |
| 2006 | 5.55 | -85,59 | -15,730 |
| 2005 | 4.36 | -16,51 | -1,700 |
| 2004 | 2.11 | -13,27 | 110 |
Bioporto A/S Aktienanalyse
What does Bioporto A/S do?
Bioporto A/S is a Danish company specializing in the development, production, and sale of diagnostic products for use in medical diagnostics. It was founded in 1999 and is headquartered in Hellerup, near Copenhagen. The company's history is closely connected to the development and marketing of biomarkers and tests. Biomarkers are biological substances that can serve as indicators for certain diseases or health conditions. Bioporto A/S specializes in the identification and development of these biomarkers, playing an important role in medical diagnostics. Its business model is based on the development and production of medical diagnostic products based on the identification of biomarkers. The company focuses on various sectors such as clinical diagnostics, the life science industry, and research and development in the diagnostic field. Bioporto A/S offers a wide range of products that cater to different customer needs. In the field of clinical diagnostics, the company provides a variety of tests and test kits for the identification of biomarkers. These include tests for determining N-terminal prohormones of brain natriuretic peptides (NT-proBNP), a biomarker used in the diagnosis of heart failure, as well as tests for detecting protein C and S, hormone receptors, or Addison's disease. In the life science industry, Bioporto A/S offers products used in the exploration of biomarkers, antibodies, and proteins. This includes antibodies that can be used for protein and protein complex analysis. Research and development of new biomarkers and diagnostic products are of great importance at Bioporto A/S. The company continually invests in the development of new tests and test kits to expand its product range and meet the ever-growing demands of medical diagnostics. Overall, Bioporto A/S is an innovative company playing an important role in medical diagnostics. With its high-quality products and close collaboration with partners in research and development, Bioporto A/S ensures it will continue to play a significant role in the identification and development of biomarkers and diagnostic products in the future. Bioporto A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Bioporto A/S's Market Capitalization
Bioporto A/S's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Bioporto A/S's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Bioporto A/S's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Bioporto A/S’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Bioporto A/S Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Bioporto A/S.
How has the market capitalization of Bioporto A/S developed in recent years?
The market capitalization of Bioporto A/S has increased/decreased by 47.49% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Bioporto A/S?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Bioporto A/S?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Bioporto A/S have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Bioporto A/S pay?
Over the past 12 months, Bioporto A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioporto A/S is expected to pay a dividend of 0 DKK.
What is the dividend yield of Bioporto A/S?
The current dividend yield of Bioporto A/S is .
When does Bioporto A/S pay dividends?
Bioporto A/S pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bioporto A/S?
Bioporto A/S paid dividends every year for the past 0 years.
What is the dividend of Bioporto A/S?
For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bioporto A/S located?
Bioporto A/S is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bioporto A/S kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bioporto A/S from 5/31/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.
When did Bioporto A/S pay the last dividend?
The last dividend was paid out on 5/31/2024.
What was the dividend of Bioporto A/S in the year 2023?
In the year 2023, Bioporto A/S distributed 0 DKK as dividends.
In which currency does Bioporto A/S pay out the dividend?
The dividends of Bioporto A/S are distributed in DKK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bioporto A/S
Our stock analysis for Bioporto A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioporto A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Bioporto A/S Revenue
- Bioporto A/S Net Income
- Bioporto A/S P/E
- Bioporto A/S P/S
- Bioporto A/S EBIT
- Bioporto A/S Dividend
- Bioporto A/S Stocks
- Bioporto A/S Market capitalization
- Bioporto A/S Debt
- Bioporto A/S Liabilities
- Bioporto A/S Equity
- Bioporto A/S AAQS
- Bioporto A/S Employees
- Bioporto A/S ROE
- Bioporto A/S ROA
- Bioporto A/S ROCE
